A cohort study of possible risk factors for over-reporting of antihypertensive adherence

P W Choo, C S Rand, T S Inui, M L Lee, C Canning, R Platt, P W Choo, C S Rand, T S Inui, M L Lee, C Canning, R Platt

Abstract

Background: The identification of poor medicinal adherence is difficult because direct observation of medication use is usually impractical. Up to 50% of individuals on chronic therapies may not be taking their medication as prescribed. This study is one of the first to explore possible risk factors for over-reporting of antihypertensive adherence using electronic medication monitoring.

Methods: The adherence of 286 individuals on single-drug antihypertensive therapy in a large managed care organization was electronically monitored for approximately three months. Questionnaires on socioeconomic background, adherence to therapy, health beliefs, and social support before and after adherence monitoring were completed. Over-reporting of antihypertensive adherence was assessed by comparing the self-reported frequency of noncompliance with that determined from electronic dosing records. Risk factors for over-reporting were identified by contingency table analysis and step-wise logistic regression.

Results: Although only 21% of participants acknowledged missing doses on one or more days per week, electronic monitoring documented nonadherence at this or a higher level in 42% of participants. The following variables were associated with over-reporting: >1 versus 1 daily dose (OR = 2.58; 95% CI = 1.50-4.41; p =.0006), lower perceived health risk from nonadherence (OR = 1.35; 95% CI = 1.10-1.64; p =.0035), and annual household income of <15,000 dollars versus >30,000 dollars (OR = 2.64; 95% CI = 1.13-6.18; p =.025).

Conclusions: Over-reporting of adherence may be affected by factors related to dosing frequency, health beliefs and socioeconomic status. This topic deserves further investigation in other patient populations to elucidate possible underlying behavioral explanations.

References

    1. Maronde RF, Chan LS, Larsen FJ, Strandberg LR, Laventurier MF, Sullivan SR. Underutilization of antihypertensive drugs and associated hospitalization. Medical Care. 1989;27:1159–1166.
    1. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Med Care. 1988;26:814–823.
    1. Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA. 1990;263:1653–1657. doi: 10.1001/jama.263.12.1653.
    1. Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R. Noncompliance in organ transplant recipients. Transplant Proc. 1989;21:833–834.
    1. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273–3277. doi: 10.1001/jama.261.22.3273.
    1. Paterson DL, Swindels S, Mohr JA, Brester MK, Vergis EN, Squier C, Wagener MM, Singh N. Adherence with protease inhibitor therapy for human immunodeficiency virus infection. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1998; San Diego, CA. p. 419.
    1. Cramer JA. Identifying and improving compliance patterns. Patient compliance in medical practice and clinical trials Edited by Cramer JA, Spilker B. pp. 387–392. New York: Raven Press, Ltd.; 1991. pp. 387–392.
    1. Rudd P, Marshall G. Resolving problems of measuring compliance with medication monitors. The Journal of Compliance in Health Care. 1987;2:23–35.
    1. Taylor DW, Sackett RB, Johnson AL, Gibson ES, Roberts RS. Compliance with antihypertensive drug therapy. Annals of the New York Academy of Sciences. 1978:390–403.
    1. Inui TS, Carter WB, Pecoraro RE. Screening for noncompliance among patients with hypertension. Med Care. 1981;19:1061–1064.
    1. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.
    1. Rand CS, Wise RA, Nides M, Simmons MS, Bleeker ER, Kusek JW, Li VC, Tashkin DP. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis. 1992;146:1559–1564.
    1. Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol. 1993;72:68D–74D.
    1. Cramer JA. Optimizing long-term patient compliance. Neurology. 1995;45 (suppl 1):S25–S28.
    1. Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846–857. doi: 10.1097/00005650-199909000-00002.
    1. Vaur L, Vaisse B, Genes N, Elkik F, Legrand C, L P. Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large-scale trial. American Journal of Hypertension. 1999;12(4 Pt 1):374–380.
    1. Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin DP. Non-predictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest. 1999;118:290–295. doi: 10.1378/chest.118.2.290.
    1. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I. conceptual framework and item selection. Med Care. 1992;30:473–483.
    1. Sherbourne CD, Hays RD, Ordway L, DiMatteo MR, Kravitz RL. Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. J Behav Med. 1992;15:447–468.
    1. Rand CS, Nides M, Cowles MK, Wise RA, Connett J, Group LHSR. Long-term metered-does inhaler adherence in a clinical trial. Am J Respir Crit Care Med. 1995;152:580–588.
    1. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication adherence. Arch Intern Med. 1990;150:1881–1884. doi: 10.1001/archinte.150.9.1881.
    1. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Medical Care. 1975;13:10–24.
    1. Kirscht JP, Rosenstock IM. Patient adherence to antihypertensive medical regimens. Journal of Community Health. 1977;3:115–124.
    1. Rosenstock IM. Why people use health services. Milbank Mem Fund Q. 1966;44:94–124.
    1. Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Annals of Internal Medicine. 1984;100:258–268.
    1. Roter DL, Hall JA. Patient-provider communication. Health Behavior and Health Education Edited by Glanz K, Lewis FM, Rimer B. pp. 206–226. San Francisco: Jossey-Bass Publishers; 1997. pp. 206–226.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir